Cognition enhancers between treating and doping the mind
- 15 February 2008
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 57 (3) , 196-213
- https://doi.org/10.1016/j.phrs.2008.02.004
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Memantine for prevention of migraine: a retrospective study of 60 casesThe Journal of Headache and Pain, 2007
- Dopaminergic genotype biases spatial attention in healthy childrenMolecular Psychiatry, 2007
- Happy birthday protein kinase C: Past, present and future of a superfamilyPharmacological Research, 2007
- Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison TrialAustralian & New Zealand Journal of Psychiatry, 2007
- Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label StudyJournal of Child and Adolescent Psychopharmacology, 2006
- Reverse replay of behavioural sequences in hippocampal place cells during the awake stateNature, 2006
- Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetineMolecular Psychiatry, 2005
- Experience-driven brain plasticity: beyond the synapseNeuron Glia Biology, 2004
- Some workmen can blame their tools: artistic change in an individual with Alzheimer's diseaseThe Lancet, 2001
- Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.Psychological Review, 1992